Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thalidomide-induced neuropathy.

V Chaudhry1, D R Cornblath, A Corse

  • 1Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. vchaudh@jhmi.edu

Neurology
|December 25, 2002
PubMed
Summary

Thalidomide can cause dose-dependent peripheral neuropathy, affecting sensory nerves more than motor nerves. Careful neurologic monitoring is essential during its use for dermatologic and oncologic conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guillain-Barré Syndrome Disability Scale.

Journal of the peripheral nervous system : JPNS·2025
Same author

Autologous fecal transplant for the treatment of microcolon due to diversion colitis.

Techniques in coloproctology·2021
Same author

Patient-reported outcomes with subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: the PATH study.

European journal of neurology·2019
Same author

Diverticular colovesical fistula: What should we really be doing?

Techniques in coloproctology·2017
Same author

Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies.

European journal of neurology·2016
Same author

[EurSafety Health-Net: MRSA Eradication in Nursing Homes and Home Care - A Practice Report].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))·2015

Area of Science:

  • Neurology
  • Pharmacology
  • Oncology

Background:

  • Thalidomide is a valuable treatment for refractory dermatologic and oncologic diseases.
  • Peripheral neuropathy is a significant toxicity limiting thalidomide use.
  • Embryopathy risks are mitigated by contraceptive measures.

Observation:

  • Seven patients with thalidomide-induced peripheral neuropathy underwent clinical and electrophysiologic assessment.
  • Thalidomide was administered for graft-vs-host disease, pyoderma gangrenosum, and discoid lupus.
  • Dosages ranged from 100 to 1,200 mg/day over 5 to 16 months.

Findings:

  • All patients exhibited sensory-predominant, axonal, length-dependent polyneuropathy with paresthesias or numbness.
  • Sural nerve biopsies revealed Wallerian degeneration and myelinated fiber loss.

Related Experiment Videos

  • Neuropathy severity correlated with the cumulative dose of thalidomide.

    • Implications:

    • Thalidomide induces a dose-dependent sensorimotor axonal neuropathy.
    • Judicious use of thalidomide with close neurologic monitoring is recommended.
    • Understanding neuropathy mechanisms aids in safer therapeutic application.